Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,783 | 543 | 99.9% |
| Education | $5.90 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $951.31 | 61 | $0 (2024) |
| ABBVIE INC. | $852.56 | 57 | $0 (2024) |
| GlaxoSmithKline, LLC. | $702.12 | 50 | $0 (2024) |
| Novo Nordisk Inc | $699.45 | 51 | $0 (2024) |
| Lilly USA, LLC | $694.43 | 65 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $664.43 | 60 | $0 (2024) |
| Amarin Pharma Inc. | $384.26 | 24 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $341.80 | 23 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $246.32 | 16 | $0 (2024) |
| Amgen Inc. | $235.98 | 18 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,708 | 120 | PFIZER INC. ($361.99) |
| 2023 | $1,268 | 80 | PFIZER INC. ($345.91) |
| 2022 | $1,905 | 137 | Novo Nordisk Inc ($239.72) |
| 2021 | $2,192 | 159 | AbbVie Inc. ($300.72) |
| 2020 | $347.34 | 23 | Eisai Inc. ($52.92) |
| 2019 | $353.86 | 24 | Novo Nordisk Inc ($71.26) |
| 2018 | $13.98 | 1 | Amgen Inc. ($13.98) |
All Payment Transactions
544 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Obesity | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: PAIN | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Hepatitis B Vaccine | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $33.72 | General |
| 11/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: PAIN | ||||||
| 10/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: VACCINES | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: PAIN | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.04 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Obesity | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 2,673 | 3,818 | $312,922 | $124,531 |
| 2022 | 39 | 2,844 | 3,916 | $318,979 | $124,811 |
| 2021 | 39 | 2,503 | 3,580 | $268,016 | $114,165 |
| 2020 | 34 | 2,169 | 3,102 | $215,968 | $81,459 |
All Medicare Procedures & Services
147 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 247 | 534 | $122,820 | $40,980 | 33.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 176 | 176 | $58,080 | $20,992 | 36.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 62 | 62 | $29,574 | $17,525 | 59.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 109 | $17,222 | $6,009 | 34.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 72 | 72 | $6,120 | $5,176 | 84.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 187 | 249 | $9,960 | $4,099 | 41.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 228 | 392 | $8,232 | $4,057 | 49.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 240 | 433 | $5,864 | $3,547 | 60.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 198 | 271 | $8,672 | $3,529 | 40.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 82 | 96 | $6,624 | $2,785 | 42.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 219 | 344 | $6,536 | $2,618 | 40.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 73 | 73 | $3,431 | $2,076 | 60.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 61 | 61 | $2,867 | $1,735 | 60.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 110 | 166 | $3,818 | $1,561 | 40.9% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 72 | 72 | $3,096 | $1,343 | 43.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 59 | 69 | $2,484 | $1,020 | 41.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 35 | 46 | $1,472 | $614.56 | 41.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 11 | 11 | $979.00 | $553.08 | 56.5% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 33 | 43 | $1,290 | $537.50 | 41.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 13 | $1,898 | $459.60 | 24.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 18 | 21 | $1,722 | $439.20 | 25.5% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 57 | 63 | $2,016 | $356.58 | 17.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 57 | 63 | $819.00 | $320.04 | 39.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 24 | 34 | $714.00 | $300.56 | 42.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 33 | $1,914 | $279.72 | 14.6% |
About Dr. Robert Ford, M.D
Dr. Robert Ford, M.D is a General Practice healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2013. The National Provider Identifier (NPI) number assigned to this provider is 1710324116.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Ford, M.D has received a total of $7,789 in payments from pharmaceutical and medical device companies, with $1,708 received in 2024. These payments were reported across 544 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($7,783).
As a Medicare-enrolled provider, Ford has provided services to 10,189 Medicare beneficiaries, totaling 14,416 services with total Medicare billing of $444,965. Data is available for 4 years (2020–2023), covering 147 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Other Specialties Student in an Organized Health Care Education/Training Program, Family Medicine
- Location Knoxville, TN
- Active Since 05/27/2013
- Last Updated 06/07/2019
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1710324116
Products in Payments
- NURTEC ODT (Drug) $703.75
- JARDIANCE (Drug) $625.99
- ELIQUIS (Drug) $604.04
- TRELEGY ELLIPTA (Drug) $531.93
- UBRELVY (Drug) $419.56
- Ozempic (Drug) $408.31
- Vascepa (Drug) $384.26
- MOUNJARO (Drug) $299.55
- VRAYLAR (Drug) $265.62
- XIFAXAN (Drug) $246.32
- TRULICITY (Drug) $242.50
- QULIPTA (Drug) $182.04
- Rybelsus (Drug) $180.98
- XARELTO (Drug) $145.69
- COMIRNATY (Biological) $142.89
- Aimovig (Biological) $123.92
- TRINTELLIX (Drug) $121.84
- Dayvigo (Drug) $118.71
- PREVNAR 20 (Biological) $115.26
- AIRSUPRA (Drug) $106.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Knoxville
Dr. David Parker, D.d.s, D.D.S
General Practice — Payments: $26,485
Matthew Bobbera, D.d.s, D.D.S
General Practice — Payments: $14,878
Dr. Andrew Young, D.d.s, D.D.S
General Practice — Payments: $13,344
Kelbin Rodriguez, Dds, DDS
General Practice — Payments: $12,814
Dr. William Strunk, D.d.s, D.D.S
General Practice — Payments: $8,665
Dr. Steven Brock
General Practice — Payments: $6,040